Related references
Note: Only part of the references are listed.Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS)
A. Wollenberg et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension
M. J. Cork et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Off-label use of dupilumab for pediatric patients with atopic dermatitis: A multicenter retrospective review
Sean Igelman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis A Phase 3 Randomized Clinical Trial
Eric L. Simpson et al.
JAMA DERMATOLOGY (2020)
Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial
Amy S. Paller et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series
L. E. M. de Wijs et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis
Ikuo Hirano et al.
GASTROENTEROLOGY (2020)
Eosinophilic Gastrointestinal Diseases in Children: A Practical Review
Amelia Licari et al.
CURRENT PEDIATRIC REVIEWS (2020)
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
Sarah Faiz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
A review of dupilumab in the treatment of atopic diseases
Quinn Thibodeaux et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Comorbidities and the impact of atopic dermatitis
Jonathan I. Silverberg
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)
Conjunctivitis in dupilumab clinical trials
B. Akinlade et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives
Amelia Licari et al.
PEDIATRIC DRUGS (2019)
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
Claus Bachert et al.
LANCET (2019)
Dupilumab for treatment of food allergy
Manuel Jorge Rial et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis
Eric L. Simpson et al.
DERMATOLOGY AND THERAPY (2019)
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
D. S. Bakker et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
William W. Busse et al.
ADVANCES IN THERAPY (2018)
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFE)
M. de Bruin-Weller et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Oral immunotherapy with omalizumab reverses the Th2 cell-like programme of regulatory T cells and restores their function
A. Abdel-Gadir et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2018)
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management
Scott H. Sicherer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
DUPILUMAB REDUCES SEVERE EXACERBATION RATE AND IMPROVES LUNG FUNCTION IN ADOLESCENT PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: FROM THE LIBERTY ASTHMA QUEST STUDY
Jorge Maspero et al.
CHEST (2018)
Commonality of the IL-4/IL-13 pathway in atopic diseases
Namita A. Gandhi et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt et al.
LANCET (2017)
The role of upper airway pathology as a co-morbidity in severe asthma
Amelia Licari et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2017)
Endotype-driven treatment in chronic upper airway diseases
Glynnis De Greve et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2017)
Targeting key proximal drivers of type 2 inflammation in disease
Namita A. Gandhi et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation
Stanley Ching-Cheng Huang et al.
IMMUNITY (2016)
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis A Randomized Clinical Trial
Claus Bachert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cells
Amir Hossein Massoud et al.
NATURE MEDICINE (2016)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Severe asthma features in children: a case-control online survey
Silvia Montella et al.
ITALIAN JOURNAL OF PEDIATRICS (2016)
Regulatory T Cell Reprogramming toward a Th2-Cell-like Lineage Impairs Oral Tolerance and Promotes Food Allergy
Magali Noval Rivas et al.
IMMUNITY (2015)
The care pathway for children with urticaria, angioedema, mastocytosis
Giuliana Ferrante et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2015)
Type 2 cytokines: mechanisms and therapeutic strategies
Thomas A. Wynn
NATURE REVIEWS IMMUNOLOGY (2015)
RHINOSINUSITIS AND ASTHMA: A VERY LONG ENGAGEMENT
A. Licari et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2014)
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A striking local esophageal cytokine expression profile in eosinophilic esophagitis
Carine Blanchard et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
IgE-mediated systemic anaphylaxis and impaired tolerance to food antigens in mice with enhanced IL-4 receptor signaling
Clinton B. Mathias et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
How are TH2-type immune responses initiated and amplified?
William E. Paul et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system
Sherry L. LaPorte et al.
CELL (2008)
Unique functions of the type 11 interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha 1 chain
Thirumalai R. Ramalingam et al.
NATURE IMMUNOLOGY (2008)
T helper type 2 differentiation and intracellular trafficking of the interleukin 4 receptor-α subunit controlled by the Rac activator Dock2
Yoshihiko Tanaka et al.
NATURE IMMUNOLOGY (2007)
Acute isolated sphenoid sinusitis in children
Gian Luigi Marseglia et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2006)
Serological detection of eotaxin, IL-4, IL-13, IFN-γ, MIP-1α, TARC and IP-10 in chronic autoimmune urticaria and chronic idiopathic urticaria
M Caproni et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2004)
TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria:: Comparison with the allergen-induced late-phase cutaneous reaction
S Ying et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Share Paper
